Our Portfolio
AIM-HI leverages its positioning within the scientific and entrepreneurial communities to identify promising startups for investment. We consistently support companies led by best-in-class scientist-entrepreneurs around the globe.
In doing so, we challenge the status quo, in which only a small percentage of such companies ever make it into commercial ventures.
We measure the success of our investments not only in fiscal return, but in patient lives saved.
Please click on each company to read more of their story.
Stories From Our Companies
Akrotome Imaging, Inc
Enhancing surgery and diagnostics with unique, cancer-targeted molecular probes to improve outcomes and patients’ quality of life
AngeLink
The world’s first fundraising platform powered by women with a mission to build a global digital donor community and create a powerful impact
Arbele
Advancing cancer detection and treatment through innovative immunosurveillance technology and platforms
Chimera Bio
Arming CAR-Ts with immunomodulatory payloads to counteract the tumor microenvironment, enabling CAR-T efficacy in solid tumors
DotBio
Developing next-generation antibody therapies by rapid prototyping and modular design
InterLeukin Combinatorial Therapies (ILCT)
A breakthrough therapy for lethal cancers by deploying novel Cancer Terminator Viruses
InVaMet Therapeutics (IVMT)
Unique target and small molecules to treat different stages of cancer progression
ManaT Bio
A pre-clinical biotech company developing precision immunotherapies targeting the most common cancer-causing mutations
Oncoheroes Biosciences
Discovering, developing, and commercializing more effective and less toxic therapies for pediatric oncology
Privo Technologies
Localized cancer therapy for a more potent and significantly safer treatment
Rasio Therapeutics
Harnessing the power of computational drug design for the identification of novel cancer therapeutics
SciTech Development
A Specialty Pharmaceutical Company Advancing Cancer Treatment Through Safer Drug Delivery
Sporos Bioventures
Developing potential breakthrough therapies for patients with cancer by targeting cancer-specific vulnerabilities & co-dependencies in the tumor microenvironment
Stromatis Pharma
Targeting unique cancer-specific antigens using powerful antibody-drug-conjugates to deliver a lethal blow to cancer
TellBio
Circulating tumor cells (CTC) diagnostics and therapeutics platform focused on freeing patients from the tyranny of cancer
Tvardi Therapeutics
Developing oral inhibitors of STAT3 as breakthrough therapies for cancer and fibrosis
Window Therapeutics
Discovering and developing transformational therapeutics to address critical unmet patient needs in life-threatening diseases.
Yiviva
Platform biotech pioneering systems biology medicines to prevent, treat and cure cancer
